Adagene (ADAG) Other Non-Current Liabilities (2020 - 2025)

Adagene's (ADAG) quarterly Other Non-Current Liabilities came in at $205.1 billion in Q4 2025, up 641.16% on a QoQ basis from $27.7 billion in Q2 2023.

Adagene (ADAG) Other Non-Current Liabilities (2020 - 2025) Analysis & Trends

Adagene (ADAG) has 5 years of Other Non-Current Liabilities data on file, last reported at $205.1 billion in Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $205.1 billion in Q4 2025; TTM through Dec 2025 was $205.1 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $205.1 billion, changed N/A from the prior year.
  • Other Non-Current Liabilities for Q4 2025 stood at $205.1 billion, up from $27.7 billion in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for ADAG reached as high as $205.1 billion in Q4 2025 and fell as low as $61919.0 in Q2 2021.
  • Historically, Other Non-Current Liabilities has averaged $48.6 billion across 4 years, with a median of $28.2 billion in 2022.
  • Across the five-year window, Other Non-Current Liabilities soared 48127292.24% in 2022 and fell 7.12% in 2023, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $94107.0 in 2021, then soared by 30516227.16% to $28.7 billion in 2022, then dropped by 3.62% to $27.7 billion in 2023, then soared by 641.16% to $205.1 billion in 2025.
  • Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $205.1 billion in Q4 2025, $27.7 billion in Q2 2023, and $28.7 billion in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Adagene 198.85 Mn 198.85 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 205.15 Bn
Jun 30, 2023 27.68 Bn
Dec 31, 2022 28.72 Bn
Jun 30, 2022 29.80 Bn
Dec 31, 2021 94,107.00
Jun 30, 2021 61,919.00
Dec 31, 2020 91,955.00